Gossamer Bio, Inc. - 8-K Filing
Gossamer Bio extended the early tender deadline for its exchange offer and consent solicitation related to $181 million in aggregate principal amount of Existing Convertible Notes until June 2, 2026. The expected early settlement date is now June 4, 2026. (Items: 8.01 Other EventsOn June 2, 2026, the Company issued a press release announcing the extension of the early tender deadline of its previously annou, 9.01 Financial Statements and Exhibits)
Tickers: $GOSS